A SPAC I Acquisition and NewGenIvf , a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, and announced that the previously announced a business combination was approved at an extraordinary general meeting of A SPAC I on March 4. The Business Combination is expected to close once all closing conditions have been met. The combined company will be named “NewGenIvf Group Limited” and its shares and warrants are expected to begin trading on the Nasdaq Capital Market under the tickers “NIVF”, and “NIVFW”, respectively. NewGen is a family of fertility clinics primarily serving patients in Southeast Asia. The company currently provides fertility services across three jurisdictions, namely Thailand, Cambodia, and Kyrgyzstan. Upon business combination closing, the combined company will be named NewGenIvf Group, and will be the only listed Asian company offering legal surrogacy services for couples as well as single parents, including the LGBTQ+ community, according to China Insight Consultancy. The company utilizes exclusive access to licensed technologies, including MicroSort. The transaction sets NewGen’s enterprise value at approximately $50M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>